IPO Renaissance IPO ETF

Expense Ratio
0.6%
Dividend
0.53%
Previous close
$49.30
Est. 12 months change
+26.10%
Projected Price
$62.17

Profitability Metrics

Return on Equity (ROE)
18.95%
Return on Assets (ROA)
4.13%
Return on Invested Capital (ROIC)
22.73%
Weighted Average Cost of Capital (WACC)
14.10%
ROIC - WACC
8.63%
Updated : 2026-05-19 19:28 ET

Valuation Metrics

P/E Ratio
29.11
Forward P/E
28.98
PEG Ratio
2.20
Debt Current Ratio
4.17

Growth & Cash Flow

Gross Margin
58.69%
Operating Margin
6.32%
FCF Margin
18.16%
TTM Revenue Growth
44.30%
Projected 12M EPS Growth
0.48%

Price Change

Price % from 50 SMA
6.59%
Price % from 200 SMA
4.40%
6 Months
13.41%
1 Year
13.15%
2 Years
24.31%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
CRWV11.28%
ALAB9.61%
ARM9.40%
KVUE8.28%
RDDT6.64%
VIK4.81%
CRCL4.53%
MDLN4.07%
RBRK2.98%
AHR2.97%

ETF Analysis

Fund Overview

Renaissance IPO ETF (IPO) currently reports 48 stock positions (subject to change), placing it in the moderately diversified range by holdings breadth. The top line-up is CRWV (11.28%), ALAB (9.61%), ARM (9.40%), with CRWV as the largest single weight at 11.28%. Together, the top three holdings account for 30.29%, which signals meaningful concentration at the top of the book, where a small number of names can drive outsized swings in fund performance. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 22.73%, WACC is 14.10%, and the economic spread is 8.63%. On balance, holdings marginally exceed their cost of capital, suggesting modest but present value creation. Supporting metrics show ROE at 18.95% and ROA at 4.13%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 29.11, forward P/E of 28.98, PEG of 2.20. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. The current ratio of 4.17 indicates holdings are well-positioned to meet near-term obligations. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 58.69%, operating margin at 6.32%, and free cash flow margin at 18.16%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin reading is below average, pointing to businesses where scaling costs remain a challenge. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

Growth & Forward Outlook

The two main inputs to the near-term picture — TTM revenue growth of 44.30% reflecting robust top-line expansion across the underlying holdings. Forecasted EPS growth of 0.5% over the next year is supportive of the current valuation, suggesting the market is not paying for earnings that won't arrive. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The composite picture leans positive, with capital efficiency and growth momentum providing the core of the investment thesis.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.